The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,612,717 in first-year total cost, median $686,084.
Most frequent study sections
- Cancer Biomarkers Study Section[CBSS]3
- Clinical Oncology Study Section[CONC]1
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL2
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
- DANA-FARBER CANCER INST1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Clinical Qualification of Imaging and Fluid-Based Tumor Monitoring Biomarkers for Metastatic Castration Resistant Prostate Cancer1R01CA240759-01A1 | MORRIS, MICHAEL JSCHWARTZ, LAWRENCE H | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | $719,712 | CBSS |
| 2020 | Using MRI and circulating tumor DNA to improve the interpretation of response to immunotherapy and targeted therapy in CNS metastases1R01CA244975-01 | BRASTIANOS, PRISCILLA KALIOPICARTER, SCOTTGERSTNER, ELIZABETH | MASSACHUSETTS GENERAL HOSPITAL, MA | $711,319 | CBSS |
| 2020 | Imaging and Liquid Biopsy for Glioma Diagnosis and Treatment Monitoring1R01CA239078-01A1 | CARTER, BOB SLEE, HAKHO | MASSACHUSETTS GENERAL HOSPITAL, MA | $660,849 | CBSS |
| 2020 | Early change in plasma tumor DNA as a patient and trial-level diagnostic in advanced lung cancer1R01CA240592-01A1 | PAWELETZ, CLOUD PETER | DANA-FARBER CANCER INST, MA | $520,837 | CONC |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.